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This study was designed to investigate a previously unidenti-
fied potential mechanism for mutation induction as well as 
to clarify a biological comequence of micronucleus forma-
tion. We compared the induction of micronuclei with 
mutation inductioo as measured by trißuorothymidine (TFI') 
resistance in mouse L5178Y cells using four aneugens: 
colcemid, diethylstilbestrol, griseofulvin and vioblastine. AU 
four compounds induced micronuclei which appeared in the 
first cell cycle after treatment. More than 85% of the 
micronuclei induced by each compound stained positive for 
the presence of kinetochores implying that the micronuclei 
contained wbole cbromosomes. However, these same com-
pounds were unable to induce TFf resistance under tbree 
different treatment regimes. We concluded that tbese 
compounds, under conditions where tbey induce primarily 
kinetochore positive micronuclel, were not able to induce 
mutations. Thus, the induction of micronuclei containing 
wbole chromosomes barborlog a select.able gene is not an early 
event leadlog to mutations in these cells. 
Introduction 
A number of investigators have monitored trifluorothymidine 
(TFT) resi.stance in L5178Y mouse cells to identify the mutagenic 
activity of chemieals (Cl ive et al. , 1972; Amacher et al. , 1980; 
Oberly etal., 1984; Caspary and Myhr, 1986; McGregoretal., 
1989, 1991; Myhr et al., 1990; Stopper et al., 1993b). The 
L5178Y mouse cell line, clone 3.7.2c, is heterozygous at the 
thymidine kinase (tk) locus. The inactive tk allele possesses a 
point mutation at position 489 changing the code from a cysteine 
to a glycine (Liechty et al., 1993). Both chemical and physical 
agents can induce TFT resistance in this cell line by producing 
the homozygote in which both tk alleles are inactivated. Cells 
heterozygous at selectable genes have a greater sensitivity to the 
mutagenic activity of chemieals than those cells that have the 
selectable gene on a single copy chromosome (Clive, 1985; Evans 
et al. , 1986; Moore et al. , 1989; McGregor et al. , 1994). 
Presumably the difference in sensitivity is due to the survival 
of a greater spectrum of mutant types in cells that are hetero-
zygous. It is believed that mutants containing multi-locus lesions, 
such as major deletions and whole chromosome losses, in the 
chromosome with the active tk allele survive because the lost 
essentialgenesthat flank this allele are present and active on the 
homologous chromosome which harbors the inactive tk allele 
(Evans et al., 1986). 
L5178Y mouse mutant colonies demonstrate a bimodal 
distribution of colony sizes and the colonies have been designated 
as small or large. The size of mutant colonies depends partially 
on the growth rates of the mutants during the cloning phase of 
the assay-slow growth Ieads to small colonies (Moore et al. , 
1985). Large colonies are due to mutations within the active 
allele. Small colonies result in part from lesions that affect not 
only the active tk allele but a flanking gene whose expression 
modulates the growth rate of the cells. Cytogenetic studies have 
shown that 40-93% of the small colonies (Hozier et al. , 1985; 
Blazak et al., 1986a,b, 1989) exhibit translocations in which 
chromosomal material is attached to a break point in the distal 
end of chromosome 11 (ehr 11) at a site close to the location 
of the tk allele (Hozier et al., 1989, 1991). Molecular studies 
confrrm the loss of large segments of the DNA in the region of 
the tk allele (Yandell et al., 1986; Clive et al., 1990; Liechty 
et al., 1993). Thus, mutations can be fonned when the tk allele 
is distal to, or located at the site of the break point at which the 
translocation is observed. However, not all small colonies are 
caused by the induction of large deletions or translocations of 
genomic material in the vicinity of the tk allele (Blazak et al. , 
1989; Clive et al., 1991). 
The L5178Y mouse cell line detects many types of mutagenic 
lesions including those leading to small colonies. We have 
reported an in situ protocol that accurately detected thesedifferent 
lesions by capturing a greater proportion of the smaller colonies 
than do conventional protocols (Rudd et al., 1990; Spencer and 
Caspary, 1994; Spencer et al., 1994). In this procedure, cells 
were immobilized immediately after treannent and the proportion 
of slowly growing mutants to the total population remained 
constant du ring the cloning phase of the assay. This procedure 
led to a mutation rate that was 50-fold greater than that found 
with the conventional protocol because slowly growing mutants 
were not diluted out and each mutation led to one mutant colony 
(Rudd et al. , 1990). Because the number of mutations is 
measured, the mutation fraction (not the mutant fraction) is the 
parameter calculated as the measure of the mutagenic activity 
of a chemical (Rudd et al., 1990; Spencer and Caspary, 1994; 
Spencer et al. , 1994). Because each chromosome would be 
expected to harbor some essential genes, whole chromosome 
Iosses might be expected to reduce the growth rate and produce 
small colonies. Therefore, we used this protocol to proviele the 
greatest chance of detecting mutants containing whole chromo-
some losses. Such Iosses might be expected when aneugens 
induce micronuclei containing whole chromosornes. Wehave also 
established that L5178Y mouse cells are suitable for measuring 
micronucleus induction by chemieals (Stopper et al., 1993a,b). 
Thus, assays for both mutations and micronuclei were perfonned 
in one cell system. 
Micronuclei contain chromatin material within a membrane 
and are found in the cytoplasm of cells. Some micronuclei contain 
whole chromosomes; others contain chromosomal fragments. The 
two types of micronuclei can be distinguished from one another 
by anti-kinetochore-antibody-staining. 
The fate of micronuclei as weil as that of the cell harboring 
the micronucleus is unknown. Theoretically, a cell which has 
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completed mitosis and formed a micronucleus which contains 
whole chromosome or a chromosomal fragment harboring a 
selectable gene should be able to form a resistaßt colony if the 
genetic infonnation in a micronucleus is not available for the cell. 
The homologous chromosome rernaining in the nucleus might 
allow it to survive and divide. In support ofthis, it has been shown 
that L5178Y cells which are monosomic for ehr 11 containing 
the tk + allele have been isolated and have survived (Evans 
et al., 1986). 
Micronucleus fonnation is a phenomenon whose biological 
consequences are unknown. It is a widely used toxicological 
endpoint in vivo (mouse bone marrow assay; Gudi et al., 1992), 
in vitro (short term tests in culUJ.re cells; Fritzenschaf et al. , 1993; 
Matsuoka et al. , 1993) and in the biomonitoring of human popula-
tions (Fenech, 1993). Micronucleus fonnation has also been 
invoked as a possible mechanism for the loss of tumor suppressor 
genes, thus contributing to neoplastic cell transformation 
(Schiffmann and DeBoni, 1991). 
The purpose of this investigation is twofold: (i) to investigate 
one potential biological consequence of the presence of 
microouclei in cells and (ii) to determine if mutation assays can 
detect loss of chromosomes mediated by the induction of 
micronuclei containing whole chromosomes. To acomplish this, 
we determined optimal conditions for micronucleus induction and 
then used the same conditions to try to induce mutations in these 
cells. 
Materials and methods 
Ozemicals 
Bisbenzinlide 33258, DES, griseofulvin, vinblastine, colcemid, ethyl 
methylsulfonate {EMS), hypoxanthine, methotrexate, thymidine, glycine, TFT, 
Tween 20 and FITC<enjugated goat anti-human antibody were purchased from 
Sigma Chemie GmbH (Dei.senhofen, Gennany). Dirnethyl sulfoxide (DMSO) 
and formamide were acquired from A1drich (Steinheim, Germany). CREST-serum 
(anti-kinetochore-antibody) was purchased from Biamann GmbH (Bad Nanheim, 
Germany). 
Cell adturt 
Mouse L5178Y cells, clone 3.7.2c (Clive et aL, 1972), were rulwred in suspension 
in RPMI-1640 medium supplemented with 95 U/ml penkillin, 95 pglml 
streptomycin, 0.25 mglml L-glutamine, 107 pglml sodium pyruvate (Sigma and 
Gibco), 0.05% pluronic (BASF Corp.) and 10% heat inactivated horse serum 
(Sigma and Hazleton Biologics). CeU rultures were grown in a humidified 
atmosphere with s% c~ in air at 37°C. 
In vitro micromu:kus a.s.say and lcinetochore analysis 
Expontentially growmg L5178Y mause ceUs with a doubling time of 10 h were 
treated for 4 h. The vehicle contro1 was 1% DMSO or ethanol. After removing 
the chemicaJs by centrifugatioo and mediwn replacement, the cells were incubaled 
for .5 h. The cells were then brought onto glass slides by cytospin centrifugation. 
Fixation was performed with methano1 (-20°C, 1 h). For staining of nuclei and 
oticronuclei, the slides were washed with distilled water, incubated with 
bisbenzimide 33258 (5 pg/m1, 3 min), washed with distilled water, aod mounted 
for microscopy. Kinetachore staining was achieved by incubating the fixed cell 
preparations [after washing for 5 min in phosphatebuffered saline (PBS)/0.1% 
Tween 20] with CREST serum for 7.5 min in a humidified chamber a1 37°C. 
After washing twice for S min in PBS/0 . .5% Tween 20, the cells were incubaled 
for 30 min with FITC-<XJnjugated goat-anlHwman antibody which had been dilutcd 
1:100 in PBS/0 . .5% Tween 20, pH = 7.4. 1bey were then washed twice in 
PBS/0.1% Tween 20 and counterstained with bisbenzimide 33258 (5 pg/m1, 
3 min). Tbis staining Oldbod provieles for the simple scoring of nuclei and 
rnicronuc1ei but does not permit the visualization of individual ceUs. Thus, using 
a magnification of 1250 x , we counted the number of nuclei in a field and then 
the nwnber of micronuclei in thal sarne field. Each da1a point reprcsents the mean 
of thrc:e siXies with 200) nuclei evaluated per slide. All experimcnts were repeated 
to insure replication of results. 
MUUUion aperimml.s 
Culnu"CS of mouse L5178Y cells were treated with mcthotrexate before each 
experimenl to kill pre-uisting TFTr ceUs. To a.ccomplish this, cells were 
incubatc:d for 24 hin culrure medium plus methotrexate (0.3 pg/ml), thymidine 
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(9 pg/ml), bypoxanthine (15 pg/ml) and glycine (22.5 p.glml). The cells were 
then inrubated for at least 48 h in the samemedium without methotrexale. To 
measure chemically induced mutations using the in sim proc.edure (Rudd ~ al. , 
1990; Spencc:r m.i Caspary, 1994; Spencer er al., 1994), culrures containing I - I 0 
X 1o6 cells in 5-10 m1 medium were treated with DMSO (vducle oontrol) or 
chemieals (dissolved in DMSO). We treated the cells with the chemieals for 4 h, 
then washed the cells twice with fresh medium. In some experiments (fable IV) 
a recovery period of S h allowing the cells to grow in suspensionwas included. 
After that, from each tested culture, 0.5- .5 x Jdi cells were added to 50 m1 
of serni-solid culrure medium ( containing 0. 2.5 % granulated agar, Baltimore 
Biological Laboralories), plated into lWO plastic 100 mm culture dishes and a1Jowed 
to solidify at room temperature. mr cells were se1ected by adding an overlay 
of TFT to a fmaJ concentnltion of 8 pglml in 10 ml semi-solid medium after 
an expressiontime of 17-44 h (as specifrcd in the Results and table legends). 
lbe cloning efflciency was detennined by adding 600 cells to 100 m1 of semi-
solid mediwn and pouring into three 100 mm culture dishes. All platcs wcre in-
cubated foratotal of 11-12 days at 37ac in 5% C~ for colony growth and 
the number of TFTr colanies was counted. 
Results 
We treated L5178Y cells for 4 h with several doses of each of 
the four aneugens-colcemid, DES, griseofulvin and vin-
blastine-and determined whether the induced micronuclei 
(Figure 1) contained whole chromosomes (Table I). 
We measured the micronucleus fraction 5 h after withdrawing 
the chemical from the medium. This time point was found to 
be optimal for these substances in preliminary experiments. The 
fact that the micronuclei were observed so early suggested that 
they were induced during the first mitosis after treatment, 
presumably by interference with the mitotic apparatus. 
The highest doses examined were determined as follows. For 
colcemid and vinblastine, the highest doses accepted for 
evaluation were those that did not induce a large percentage of 
cells containing multiple micronuclei. At 0.5 JLg/ml, colcemid 
induced 181 ± 12 micronuclei per 2000 cells and at 0.05 JLg/ml, 
vinblastine induced 234 ± 82 micronuclei per 2000 cells. In both 
cases more than half of the micronucJei were in cells containing 
two or more micronuclei and, consequently, these concentrations 
were not included in Figure I. Griseofulvin and DES were 
investigated only at soluble concentrations. Griseofulvin reached 
its detectable solubility Iimit at 200 JLg/ml and DES at - 25 J.'g/ml 
in cu1ture medium. 
Colcemid, griseofulvin and vinblastine elicited an increased 
response with increasing dose up to the maximum concentration 
examined. DES, however, reached a maximum micronucleus 
fraction at - 12.5 pglml after which it decreased. It is possible 
that the solubility Iimit was reached at lower concentrations than 
those at which it was visibly detectable in the medium, which 
may have resulted in the decrease in the micronucleus fraction. 
Tabte I. Presence of kinetochores in m.icronuc1ei 
Substance 
Control 
Co1cemid 
DES 
Griseofulvin 
Vinblastine 
Dose 
{pg/ml) 
I~ DMSO 
0.1 
12.5 
100 
0.02.5 
Micronuclei/ 
2000 cel1s 
s 
69 
35 
28 
53 
Percentage of 
micronuclei 
containing 
kinetochores 
19.5 ± 4.9 
94.7 ± 1.5 
89.3 ± 3.2 
87.4 ± 2.8 
96.3 ± 2.1 
Kinetochore staining was achieved by incubating lhe fixed ceU preparations 
with CREST serurn. For the percentage of micronuclei containing 
kinetochores, each data point n:presents the mean of thrte slides ± the 
smndard devuuion. Foreach substance, 100 micronuclei on each of three 
slides were scored for the presence of a signal. 
With all four corrqx>Unds, the lowest doses at which micronuclei 
were observed were relatively non-toxic based on a measure-
ment of cloning efficiency (Tables II-IV). 
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Staining of kinetochores showed that all four compounds 
induced high percentages ( > 85%) of kinetochore-positive 
micronuclei (Table I). We concluded that the compounds 
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F'tg. 1. Micronucleus induction by four aneugens. Mouse L5178Y <:ells were ueated with the four chemieals at the conccntrations shown. Standard deviations 
are shown by the bars on the graphs. 
Table 0. Absence of mutation induction in LS178Y mouse cells by aneugens-40-44 h expression 
Substance pg/ml Experiment A Experiment B Experiment C 
MnF (RMnf) CE MnF (RMnF) CE MnF (RMnF) CE 
Colcemid 0 159 ± 5 (1.0) 0.66 118 (1.0) 0.68 276 (1.0) 0.62 
0.1 239 ± 40 (1.5) 0.54 
0.2 239 ± 12 (1.5) 0.62 171 ± 35 (1.4) 0.51 346 (1.3) 0.70 
0.4 198 ± 63 (1.3) 0.55 
EMS 250 1106 ± 133 (7.0) 0.53 1054 (8.9) 0.59 
DES 0 272 ± 79 (1.0) 0.96 118 (1.0) 0.68 415 ± 83 (1.0) 0.37 
12.5 242 ± 52 (0.9) 0.98 172 ± 18 (1.5) 0.58 
15 563 ± 21 (1.4) 0.21 
25 261 ± I (1.0) 1.01 
50 347 ± 83 (0.8) 0.13 
EMS 250 1683 ± 189 (6.2) 0.84 1054 (8.9) 0.59 
300 37S3 ± 561 (9.0) 0.22 
Griseofulvin 0 288 (1.0) 0.50 118 (1.0) 0.68 276 (1.0) 0.62 
25 294 (1.0) 0.53 
50 355 (1.2) 0.31 
100 290 (1.0) 0.51 
150 206 (0.7) 0.36 168 (1.4) 0.59 362 (1.3) 0.47 
EMS 250 1298 (4.5) 0.59 1054 (8.9) 0.59 
Vinbl.astine 0 159 ± 5 (1.0) 0.66 276 (1.0) 0.62 220 (1.0) 0.71 
0.025 242 ± 28 (1.5) 0.39 
0.05 207 ±50 (1.3) 0.41 367 (1.3) 0.57 293 {1.3) 0.71 
0.1 172 wt 66 (1.1) 0.56 
EMS 250 1106 ± 133 (7.0) 0.53 1452 {6.6) 0.51 
MUWion.s were mea.sured using lhe in siru procedure. Treatment time was 4 h, exprcssion time 40-44 h. MnF = mutation fraction. MnFs with '±' were 
perfonned in duplicate and the Slandard deviation is mown. MnFs without '±' were not conducted in duplicate. RMnF = relative mutation fraction. CE = 
cloning effrciency. DES = diethylstilbestrol. EMS = ethyl methanesulfonate. 
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Table m. Abseoce of mutation induction in 1...5178Y mouse cells by aneugens-17 h expression 
Substarlee l'glml Experiment A Ex~rimeru B Experiment c 
MnF (RMnF) CE MnF (RMnF) CE MnF (RMnF) CE 
Colcernid 0 46 (1.0) 0.66 
0.2 29 (0.6) 0.56 
DES 0 23 :i: 7 (1.0) 0.96 12 :i: 1 (1.0) 1.12 32 :i: 11 (1.0) 0.96 
12.5 28 :i: 1 (1.2) 0.98 26 :i: 4 (2.1) 0.66 43 ± 5• (1.3) 0.98 
20 20 :i: 2 (1.7) 0.67 
2S 26 :i: 13 (1.1) 1.01 38 :I: 11 (1.2) 1.01 
EMS 250 15 :I: 3 (1.3) 0.79 
300 23 (1.0) 0.84 66 :i: 21 1 (2.1) 0.84 
Griseofulvin 0 46 (1.0) 0.66 
ISO 34 (0.7) 0.65 
V inblastine 0 46 (1.0) 0.66 
0.05 35 (0.8) 0.84 
Mutations were rneasured using the in situ proccdure. Treatment time was 4 h, expression time 17 h ('22.25 h). MnF = mutation fraction. MnFs with '±' 
were performed in duplicate and the staDdard deviation is shown. MnFs without • ± ' were not conducted in duplicate. RMnF = relative mutation fraction. 
CE = cloning efficiency. EMS = ethyl methanesulfonate. DES = dicthylstilbestrol. 
Table m. Absence of mutation induction in 1...5178Y mouse cells by aneugens-5 h recovery + 40 h expression 
Substance l'glml Experiment A Experiment B Experiment C 
MnF (RMnF) CE MnF (RMnF) CE MnF (RMnF) CE 
Colcemid 0 344 (1.0) 0.62 441 (1.0) 0.56 361 (1.0) 0.53 
0.2 422 (1.2) 0.41 287 (0.7) 0.38 329 (0.9) 0.42 
EMS 250 1115 (3.2) 0.67 941 (2.1) 0.70 894 (2.5) 0.79 
DES 0 235 (1.0) 0.87 
12.5 223 :i: 321 (0.9) 0.65 
20 184 :i: 40 (0.8) 0.57 
EMS 250 986 :1: 23 (4.2) 0.85 
Griseofulvin 0 344 (1.0) 0.62 441 (1.0) 0.56 361 (1.0) 0.53 
150 341 (1.0) 0.37 226 (0.5) 0.69 352 (1.0) 0.58 
EMS 250 1115 (3.2) 0.67 941 (2.1) 0.70 894 (2.5) 0.79 
Vinblastine 0 344 (l.O) 0.62 441 (1.0) 0.56 361 (1.0) 0.53 
0.05 380 (1.1) 0.66 202 (0.5) 0.66 223 (0.6) 0.71 
EMS 250 1115 (3.2) 0.67 941 (2.1) 0.70 894 (2.5) 0.79 
Mutations were measured using the in situ procedure. Treatment time was 4 h, then cells were allowed to grow in suspension for 5 h before being plated for 
an expression time of 40-44 h. MnF = mutation fraction. MnFs with • ±' were perfonned in duplicate and the standard deviation is shown. MnFs without 
• ±' were not conductcd in duplicate. ('Average of five treatcd cu1tures.) RMnF .. relative mutation fraction. CE = cloning efficiency. EMS = ethyl 
methanesulfonate. DES = diethylstilbestrol. 
examined induced the enclosure of whole chromosomes into 
micronuclei in these cells. In control cultures, which averaged 
-3 or 4 micronuclei per 2000 cells, 19.5% ofthe micronuclei 
were kinetochore positive showing that micronuclei can contain 
chromosomal fragments in these cells. These micronuclei data 
are consistent with mechanisms in which mitosis is perturbed 
resulting in lagging chromosomes and the fonnation of micro-
nuclei containing whole chromosomes. 
Next, we examined the four aneugenic compounds and EMS 
(as a positive control) for mutagenicity as measured by the 
induction of TFf resistance in these cells. Three different 
modifications of the protocol were used. 
A dose- response experiment for mutation was performed with 
each substance (Table Il). Earlier investigations showed that the 
in situ expression of chemically induced mutation in L5178Y cells 
can be expected at -40-50 h (Spencer and Caspary, 1994; 
Spencer et al., 1994). Therefore, we chose a 40-44 h expression 
time and treated the cells using the same dose range as in the 
micronucleus experiments. EMS clearly caused an elevated 
mutation fraction in each of the experiments. The highest relative 
mutation fraction (RMnF) of 1.5 for the aneugens was not 
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reproducible. We concluded that no significant increase could 
be observed with the four aneugens. 
However, the optimal time for mutation would be expected 
to depend on the mechanism leading to mutation. It is believed 
that aneugens induce micronuclei by causing the chromosomes 
to lag during mitosis and this would occur during the first cell 
division after treatment. It would be expected that mutation 
expression would be earlier for treatment with aneugens than with 
treatment with compounds that form DNA adducts. Such 
compounds, for example EMS, can require up to two cell 
divisions for the mutation to be fixed. Therefore, we looked at 
the mutagenic response after a 17 h expression time. We observed 
no significant increase in the mutation fraction (RMnF s 1. 7) 
with any of the aneugenic substances at this early expression time 
(Table Ill), with the exception perhaps of DES at 12.5 J.tg/ml 
(experiment B). However this responsewas not duplicated in the 
other experirnents shown or in other replicate experiments that 
we performed. As expected, the mutation fractions for EMS at 
a 17 h expression time were in the same range as for the 
aneugens. 
Since aneugens presumbly act on the mitotic apparatus of cells 
during rnitosis, L5178Y mouse cells rnight be especially 
susceptible to dying if they were in mitosis at the time of plating. 
To counter that possibility, we modified the mutation protocol 
to allow a 5 h recovery period between treatment and plating 
ofthe cells and assessed the mutagenic response after an additional 
expression of 42 h. Again we observed no response for the four 
aneugens (Table IV). 
Under the various conditions used here, none of the 
aneugens-colcemid, DES, griseofulvin and vinblastine-induced 
TFf resistance with any of the treannent protocols used, at doses 
in the same range as those in which they produced micronuclei. 
EMS showed a signiticant induction of mutation fractions in our 
experiments. 
Discussion 
Under conditions where they induced micronuclei, the aneugens 
examined did not induce mutations in L5178Y mouse cells at 
the tk locus. This suggested that the induction of micronuclei 
containing whole chromosomes was not an early event leading 
to phenotypically expressed mutations in these cells. However, 
if Chromosomes were not randomly excluded from the nucleus 
to fonn a micronucleus, it is possible that chromosome 11 might 
not be found in any of the micronuclei. If this were the case, 
the L5178Y mutation assay would not be an appropriate assay 
to measure the results of micronucleated cells because it measures 
mutation at chromosome 11. However, it should be noted that 
there is no evidence suggesting that chromosome 11 is not being 
expelled from the nucleus to form a rnicronucleus. 
If micronucleated cells survive and grow, their effect on the 
mutation fraction should be readily observed. In our experiments, 
we exarnined aneugen doses that induced - 40 or more 
micronuclei per 2000 cells. There are 40 chromosomes in the 
mouse; if we assume that whole chromosomes are randomly 
excluded from the nucleus, then the number of cells which form 
micronuclei containing ehr 11 containing the zk+ allele is one 
per 2000 cells. If each of these cells were to survive to form 
a mutant we could expect an induced mutation fraction of 500 
mutations per million cells. The spontaneous mutation fractions 
in our experiments generally were in the range of 100-300 
mutations per million cells at 40-44 h expression and <50 
mutations per million cells at 17 h. Thus, if the micronuc1eated 
cells survive and divide, the additional induced mutation fraction 
of 500 mutations per million cells should be detectable. lf 
micronucleated cells did not survive, there would be no mutants 
to count because dead mutants cannot be scored. 
The reason for the seeming refractivity of L5178Y cells to the 
mutagenic activity of aneugens may have to do with the fate of 
the micronucleus, which is not known. A micronucleated cell 
might die, resulting in the disintegration of the micronucleus, 
or it might be cytostatic and not divide further to form a mutant 
colony. Alternatively, a micronucleus might disintegrate resulting 
in a cell lacking 8 chromosome and the cell in turn might die 
in which case it would not result in a viable mutant. It could 
survive with 8 reduced complement of chromosomes or duplicate 
the remaining chromosome and possess 8 chromosome comple-
ment containing two identical chrs 11 each containing the inactive 
tk allele. L5178Y cells that lost a whole ehr 11 containing the 
inactive tk allele have been described and shown to grow in 
cu1ture (Evans et al. , 1986). This suggests that L5178Y cells 
lacking a ehr 11 can survive. Altematively, the chromosome may 
reintegrate into the nucleus of the ceU, reincarnating a wild-type 
cell that does not possess a mutant phenotype. 
It appears that L5178Y mouse cells cannot be expected to detect 
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aneugens at the tk locus. It is not known whether this conclusion 
can be generalized to other mutation assay systems. The four 
aneugens that we chose, colcemid, DES, griseofulvin and 
vinblastine, have not been srudied extensively for their mutagenic 
propenies in mammalian cells. We could find information only 
on DES. The evidence presented for DES indicates that this 
compound is not mutagenic in mammalian cells in culture (Barrett 
et al. , 1981 , 1983; Drevon et al. , 1981; Mitchell et al. , 1988; 
Myhr et al., 1988). However, some variability has been reported 
(Clive et al., 1979; Myhr et al., 1985). However, the positive 
responses in these latter studies occurred at doses that may have 
been insoluble ( 2::25 J!g/ml), though other effects may be respon-
sible for the responses observed. The hprt locus would not be 
expected to detect aneugenic compounds because of the 
unavailability of a homologous chromosome. It appears that if 
an aneugen is tobe detected, another assay like the micronucleus 
test needs to be used. 
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